Cerebrolysin is a multi-modal neuropeptide drug with a fast onset of action that helps to regain and maintain the independence of patients suffering from stroke, TBI, dementia and cognitive impairment. Cerebrolysin ® improves the brain’s ability for self-repair by stimulating neurorecovery.
 
Cerebrolysin contains low molecular weight biologically active neuropeptides that penetrate the BBB (blood-brain barrier) and directly enter the nerve cells. The drug has an organ-specific multimodal effect on the brain, i.e., provides metabolic regulation, neuroprotection, functional neuromodulation, and neurotrophic activity.